Publications
5532 Results
- Journal / Conference
- Modern Pathology 5(1):81A(#478)
- Year
- 1992
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8819
Diffuse small cleaved cell lymphoma (DSCL): Correlation of BCL-1 and BCL-2 gene rearrangements with survival.
- Journal / Conference
- AACR 33:467(#2791)
- Year
- 1992
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8819
Lineage restricted MDR1 expression in normal blood cells.
- Journal / Conference
- Modern Pathology 5:78A(#458)
- Year
- 1992
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8819
Molecular analysis of CD3(+) and CD3(-) peripheral T-cell lymphomas (RTCL).
- Journal / Conference
- ASCO 11:294(#987)
- Year
- 1992
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-8836
Concurrent daily low-dose cisplatin (LDCP) combined with chest irradiation (RT) in locally advanced non-small cell lung cancer: Preliminary results of a Southwest Oncology Group study.
- Journal / Conference
- ASCO 11:219(#692)
- Year
- 1992
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8956
Significant response rate to cisplatin + 5-fluorouracil in advanced/recurrent bladder cancer. A preliminary report. A Southwest Oncology Group study.
- Journal / Conference
- AACR 33:225(#1346)
- Year
- 1992
- Research Committee(s)
- Head and Neck
- Study Number(s)
- SWOG-8957
Post-operative radiotherapy + cisplatin followed by three courses 5-fluorouracil + cisplatin in resected head and neck cancer patients - preliminary report. A Southwest Oncology Group study.
- Journal / Conference
- ASCO 11:297(#994)
- Year
- 1992
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9038
Treatment of stage IV non-small cell lung cancer (NSCLC) with long term administration of oral etoposide (E) and oral cyclophosphamide (C). A Southwest Oncology Group study.
- Journal / Conference
- ASCO 11:315(#1066)
- Year
- 1992
The proliferative rate of aggressive non-Hodgkin's lymphomas identifies a patient group with fatal disease: A prospective Southwest Oncology Group trial.
- Journal / Conference
- ASCO 11:57(#53)
- Year
- 1992
A recursive partitioning and amalgamation (RPA) analysis of the Southwest Oncology Group node+ adjuvant CMFVP data base: Four distinct prognostic groups are described by age, ER and number of nodes.
- Journal / Conference
- American Urological Association Inc. :#848
- Year
- 1992